首页> 外文期刊>Nature clinical practice. Cardiovascular medicine >Screening, stem cells, biomarkers and hypercholesterolemia: our first original clinical research
【24h】

Screening, stem cells, biomarkers and hypercholesterolemia: our first original clinical research

机译:筛查,干细胞,生物标志物和高胆固醇血症:我们的第一项原始临床研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

It's been a busy few months since we launched our call for original clinical research. What started as an encouraging trickle has become a steady flow of outstanding submissions. Without further ado, we're delighted to introduce our first original papers, now available online.Rheumatic heart disease (RHD) is a huge problem, with low-income countries being the worst affected. The true prevalence of RHD is, however, uncertain; only screening can indicate true disease burden. In our first paper, Jonathan Carapetis and his research group document the highest echocardiographically confirmed prevalence of RHD reported to date-3.3% of children surveyed had definite RHD.
机译:自从我们发起对原始临床研究的呼吁以来已经忙了几个月。最初令人鼓舞的trick细流已逐渐涌现出大量优秀论文。事不宜迟,我们很高兴地介绍我们的第一篇原创论文,现在可在线获得。风湿性心脏病(RHD)是一个巨大的问题,低收入国家受到的影响最大。然而,RHD的真正患病率尚不确定。只有筛查才能表明真正的疾病负担。在我们的第一篇论文中,乔纳森·卡拉佩蒂斯(Jonathan Carapetis)和他的研究小组记录了迄今为止经超声心动图确认的RHD患病率最高的数据,接受调查的3.3%的儿童患有RHD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号